ZA200708203B - 2-Sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors - Google Patents
2-Sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitorsInfo
- Publication number
- ZA200708203B ZA200708203B ZA200708203A ZA200708203A ZA200708203B ZA 200708203 B ZA200708203 B ZA 200708203B ZA 200708203 A ZA200708203 A ZA 200708203A ZA 200708203 A ZA200708203 A ZA 200708203A ZA 200708203 B ZA200708203 B ZA 200708203B
- Authority
- ZA
- South Africa
- Prior art keywords
- sulfinyl
- sulfonyl
- imidazole derivatives
- substituted imidazole
- cytokine inhibitors
- Prior art date
Links
- -1 2-sulfonyl-substituted imidazole Chemical class 0.000 title abstract 2
- 102000004127 Cytokines Human genes 0.000 title abstract 2
- 108090000695 Cytokines Proteins 0.000 title abstract 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
Abstract
The invention relates to 2-sulfinyl- or 2-sulfonyl-substituted imidazole derivatives of the formula (I) in which the radicals R1, R2, R3 and R4 have the meaning indicated in the description. The compounds of the invention have an immunomodulating and/or cytokine release-inhibiting effect and are therefore suitable for the treatment of disorders associated with an impairment of the immune system.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05004369 | 2005-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200708203B true ZA200708203B (en) | 2008-10-29 |
Family
ID=34933989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200708203A ZA200708203B (en) | 2005-02-28 | 2007-09-26 | 2-Sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
Country Status (20)
Country | Link |
---|---|
US (1) | US20100273833A1 (en) |
EP (1) | EP1853581B1 (en) |
JP (1) | JP2008531627A (en) |
KR (1) | KR20070107082A (en) |
CN (1) | CN101128453A (en) |
AT (1) | ATE469893T1 (en) |
AU (1) | AU2006218037B2 (en) |
BR (1) | BRPI0608739A2 (en) |
CA (1) | CA2599449A1 (en) |
DE (1) | DE602006014657D1 (en) |
DK (1) | DK1853581T3 (en) |
ES (1) | ES2351308T3 (en) |
IL (1) | IL184745A0 (en) |
MX (1) | MX2007010496A (en) |
NO (1) | NO20074912L (en) |
NZ (1) | NZ560264A (en) |
PT (1) | PT1853581E (en) |
RU (1) | RU2007135955A (en) |
WO (1) | WO2006089798A1 (en) |
ZA (1) | ZA200708203B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1894925A1 (en) * | 2006-08-24 | 2008-03-05 | Merckle Gmbh | Imidazole compounds having an antiinflammatory effect |
US8143294B2 (en) | 2007-12-31 | 2012-03-27 | Michael Burnet | 2-sulfanyl-substituted imidazole derivatives and their use as cytokine inhibitors |
CN102249992A (en) * | 2011-07-05 | 2011-11-23 | 广东工业大学 | Method for preparing 2-aminoisonicotinic acid |
WO2017151409A1 (en) | 2016-02-29 | 2017-09-08 | University Of Florida Research Foundation, Incorporated | Chemotherapeutic methods |
HRP20221196T1 (en) | 2017-10-05 | 2022-12-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010014288A (en) * | 1997-06-30 | 2001-02-26 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 2-Substituted imidazoles useful in the treatment of inflammatory diseases |
GB9713726D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
ES2260033T3 (en) * | 1999-07-02 | 2006-11-01 | Stuart A. Lipton | USE OF P38 MAPK INHIBITORS IN OPHTHALMIC EFERMADADES. |
DE10107683A1 (en) * | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituted imidazole derivatives and their use in pharmacy |
DE10114775A1 (en) * | 2001-03-26 | 2002-10-10 | Gerhard Dannhardt | 2-Mercapto-4,5-diarylimidazole derivatives and their use in pharmacy |
KR20020009532A (en) * | 2001-11-13 | 2002-02-01 | (주)쎌믹스 | Composition for the inhibition against leucotrienes production |
DE10222103A1 (en) * | 2002-05-17 | 2003-11-27 | Merckle Gmbh Chem Pharm Fabrik | New 2-(substituted thio)-imidazole derivatives are immunomodulators and cytokine release inhibitors, useful for treating diseases associated with immune system disorders, e.g. cancer or rheumatoid arthritis |
DE10238045A1 (en) * | 2002-08-20 | 2004-03-04 | Merckle Gmbh Chem.-Pharm. Fabrik | 2-Thio-substituted imidazole derivatives and their use in pharmacy |
-
2006
- 2006-02-27 DK DK06723133.2T patent/DK1853581T3/en active
- 2006-02-27 WO PCT/EP2006/001801 patent/WO2006089798A1/en active Application Filing
- 2006-02-27 PT PT06723133T patent/PT1853581E/en unknown
- 2006-02-27 CN CNA2006800062247A patent/CN101128453A/en active Pending
- 2006-02-27 NZ NZ560264A patent/NZ560264A/en not_active IP Right Cessation
- 2006-02-27 US US11/817,298 patent/US20100273833A1/en not_active Abandoned
- 2006-02-27 KR KR1020077019748A patent/KR20070107082A/en not_active Application Discontinuation
- 2006-02-27 MX MX2007010496A patent/MX2007010496A/en not_active Application Discontinuation
- 2006-02-27 BR BRPI0608739-6A patent/BRPI0608739A2/en not_active IP Right Cessation
- 2006-02-27 DE DE602006014657T patent/DE602006014657D1/en active Active
- 2006-02-27 CA CA002599449A patent/CA2599449A1/en not_active Abandoned
- 2006-02-27 JP JP2007557404A patent/JP2008531627A/en active Pending
- 2006-02-27 RU RU2007135955/04A patent/RU2007135955A/en not_active Application Discontinuation
- 2006-02-27 AT AT06723133T patent/ATE469893T1/en not_active IP Right Cessation
- 2006-02-27 AU AU2006218037A patent/AU2006218037B2/en not_active Ceased
- 2006-02-27 ES ES06723133T patent/ES2351308T3/en active Active
- 2006-02-27 EP EP06723133A patent/EP1853581B1/en active Active
-
2007
- 2007-07-19 IL IL184745A patent/IL184745A0/en unknown
- 2007-09-26 ZA ZA200708203A patent/ZA200708203B/en unknown
- 2007-09-27 NO NO20074912A patent/NO20074912L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2599449A1 (en) | 2006-08-31 |
JP2008531627A (en) | 2008-08-14 |
ATE469893T1 (en) | 2010-06-15 |
AU2006218037B2 (en) | 2012-04-05 |
RU2007135955A (en) | 2009-04-10 |
WO2006089798A1 (en) | 2006-08-31 |
NO20074912L (en) | 2007-11-28 |
CN101128453A (en) | 2008-02-20 |
DE602006014657D1 (en) | 2010-07-15 |
NZ560264A (en) | 2009-11-27 |
PT1853581E (en) | 2010-09-09 |
ES2351308T3 (en) | 2011-02-02 |
EP1853581B1 (en) | 2010-06-02 |
DK1853581T3 (en) | 2010-09-27 |
AU2006218037A1 (en) | 2006-08-31 |
US20100273833A1 (en) | 2010-10-28 |
EP1853581A1 (en) | 2007-11-14 |
IL184745A0 (en) | 2007-12-03 |
KR20070107082A (en) | 2007-11-06 |
BRPI0608739A2 (en) | 2011-03-15 |
MX2007010496A (en) | 2007-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100051I1 (en) | Compositions and methods of treating cell proliferation disorders | |
MX2011012353A (en) | N-(HETERO)ARYL-PYRROLIDINE DERIVATIVES OF PYRAZOL-4-YL-PYRROLO[2, 3-d]PYRIMIDINES AND PYRROL-3-YL-PYRROLO[2,3-d]PYRIMIDINES AS JANUS KINASE INHIBITORS. | |
TNSN07323A1 (en) | Imidazo (1, 2-a) pyridine compounds as vegf-r2 inhibitors | |
UA102858C2 (en) | Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof | |
GEP20084550B (en) | Substituted morpholine compounds for the treatment of central nervous system disorders | |
TW200714590A (en) | Heterocyclic inhibitors of MEK and methods of use thereof | |
UA83875C2 (en) | Quinoline derivatives for use as mycobacterial inhibitors | |
PT2334677E (en) | Triazolopyridine compounds as pim kinase inhibitors | |
IL163781A0 (en) | Purine derivatives as kinase inhibitors | |
EP2185514A4 (en) | Vinyl-aryl derivatives for inflammation and immune-related uses | |
MX2008001538A (en) | 2-aminoaryl pyridines as protein kinases inhibitors. | |
TW200630367A (en) | Substituted adenines and the uses thereof | |
MX2010000098A (en) | Polycyclic guanine derivatives and use thereof. | |
MY147649A (en) | Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders | |
MY147268A (en) | Ketomethionine ketals and their derivatives | |
MX2010005047A (en) | Aldh-2 inhibitors in the treatment of psychiatric disorders. | |
IL205696A0 (en) | Heterocyclic derivatives, compositions comprising the same and uses thereof | |
MX2009002842A (en) | HETEROCYCLIC INHIBITORS OF c-MET AND USES THEREOF. | |
NO20055563L (en) | Means for the treatment of lower abdominal disorders | |
JO2682B1 (en) | 7-ALkynyl-1,8-Naphthyridone Derivatives, Preparation Thereof And Therapeutic Use Thereof | |
ZA200708203B (en) | 2-Sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors | |
MX2010003563A (en) | C-met protein kinase inhibitors. | |
MXPA03007380A (en) | 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry. | |
UA94054C2 (en) | Nitrocatechol derivatives as comt inhibitors | |
NO20051477L (en) | 2-thio-substituted imidazole derivatives and their use in pharmaceuticals |